Advantech Capital Partners Ii Limited - Net Worth and Insider Trading

Advantech Capital Partners Ii Limited Net Worth

The estimated net worth of Advantech Capital Partners Ii Limited is at least $221 Million dollars as of 2024-11-11. Advantech Capital Partners Ii Limited is the of Alphamab Oncology and owns about 49,691,190 shares of Alphamab Oncology (HKSE:09966) stock worth over $221 Million. Details can be seen in Advantech Capital Partners Ii Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Advantech Capital Partners Ii Limited has not made any transactions after 2019-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Advantech Capital Partners Ii Limited

To

Advantech Capital Partners Ii Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Advantech Capital Partners Ii Limited owns 1 companies in total, including Alphamab Oncology (HKSE:09966) .

Click here to see the complete history of Advantech Capital Partners Ii Limited’s form 4 insider trades.

Insider Ownership Summary of Advantech Capital Partners Ii Limited

Ticker Comapny Transaction Date Type of Owner
HKSE:09966 Alphamab Oncology 2019-12-12

Advantech Capital Partners Ii Limited Latest Holdings Summary

Advantech Capital Partners Ii Limited currently owns a total of 1 stock. Advantech Capital Partners Ii Limited owns 49,691,190 shares of Alphamab Oncology (HKSE:09966) as of December 12, 2019, with a value of $221 Million.

Latest Holdings of Advantech Capital Partners Ii Limited

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:09966 Alphamab Oncology 2019-12-12 49,691,190 4.45 221,125,796

Holding Weightings of Advantech Capital Partners Ii Limited


Advantech Capital Partners Ii Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Advantech Capital Partners Ii Limited has made a total of 1 transactions in Alphamab Oncology (HKSE:09966) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Alphamab Oncology is the sale of 0 shares on December 12, 2019, which brought Advantech Capital Partners Ii Limited around $0.

Insider Trading History of Advantech Capital Partners Ii Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Advantech Capital Partners Ii Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Advantech Capital Partners Ii Limited Ownership Network

Ownership Network List of Advantech Capital Partners Ii Limited

No Data

Ownership Network Relation of Advantech Capital Partners Ii Limited

Insider Network Chart

Advantech Capital Partners Ii Limited Owned Company Details

What does Alphamab Oncology do?

Who are the key executives at Alphamab Oncology?

Advantech Capital Partners Ii Limited is the of Alphamab Oncology. Other key executives at Alphamab Oncology include 2301 Trustee South Dakota Trust Company Llc , 2305 Beneficiary of a trust Xu Ting , and 2307 Founder of a discretionary trust who can infl LIU YANG .

Alphamab Oncology (HKSE:09966) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alphamab Oncology (HKSE:09966) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alphamab Oncology (HKSE:09966) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alphamab Oncology (HKSE:09966)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alphamab Oncology Insider Transactions

No Available Data

Advantech Capital Partners Ii Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Advantech Capital Partners Ii Limited. Currently GuruFocus does not have mailing address information for Advantech Capital Partners Ii Limited.